P
Purple Biotech Ltd
TASE:PPBT
Purple Biotech Ltd
TASE:PPBT
Price:
20 ILS
-10.31%
Market Closed
Updated:
May 5, 2024
Purple Biotech Ltd
Cash from Investing Activities
|
Purple Biotech Ltd
Cash from Investing Activities Peer Comparison
Comparables:
T
TEVA
TARO
I
INCR
MDWD
R
REKA
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
P
|
Purple Biotech Ltd
TASE:PPBT
|
Cash from Investing Activities
$13.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
T
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Cash from Investing Activities
$968m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
Taro Pharmaceutical Industries Ltd
NYSE:TARO
|
Cash from Investing Activities
$148.1m
|
CAGR 3-Years
373%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
I
|
InterCure Ltd
TASE:INCR
|
Cash from Investing Activities
-₪147.2m
|
CAGR 3-Years
-58%
|
CAGR 5-Years
-286%
|
CAGR 10-Years
-74%
|
|
|
Mediwound Ltd
NASDAQ:MDWD
|
Cash from Investing Activities
-$34.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-28%
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Cash from Investing Activities
-₪20.4m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-15%
|
See Also
What is Purple Biotech Ltd's Cash from Investing Activities?
Cash from Investing Activities
19.9m
USD
19.9m
USD
Based on the financial report for Dec 31, 2022, Purple Biotech Ltd's Cash from Investing Activities amounts to 19.9m USD.
What is Purple Biotech Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
48%
48%
Over the last year, the Cash from Investing Activities growth was 49%.
You don't have any saved screeners yet
